The binding of a virus particle to the surface receptors of a host cell is mediated by viral proteins, which specifically recognize receptor determinants, such as peptides, lipids or carbohydrates\[[@CIT1]\]. The receptor determinants of Influenza virus are shown to be sialic acid residues, which constitute more than 20 naturally occurring derivatives of neuraminic acid collectively referred to as a family of sialic acids. These are found widely distributed in animal tissues and in bacteria, especially in glycoproteins and gangliosides. Influenza A and B bind to the most abundant sialic acid, N-acetyl neuraminic acid (Neu5Ac or NANA). The binding of influenza A virus is mediated by the major virus surface glycoprotein, hemagglutinin (HA) that binds to the terminal sialic acid residues as the first step of viral infection and mediates both the initial attachment of virus to target cells and the subsequent fusion of the viral and cell membranes\[[@CIT2]\]. The region of the HA involved in receptor binding has been deduced from studies of mutant HAs with different binding specificities to involve a pocket of amino acids at its membrane distal surface\[[@CIT3]\]. The three-dimensional structure of influenza virus HAs complexed with cell receptor analogues show neuraminic acid bound to this pocket fundamentally through hydrogen bonds and van der Waals interactions\[[@CIT4]\].

Based on this knowledge, it should, in principle be possible to find a neuraminic acid analogue that mimics the cell receptor and thus preferentially binds to the virus, thereby blocking attachment. One approach in the design of high-affinity inhibitors is to use Neu5Ac (or its 2α-O-methyl derivative) as a scaffold and to modify its functional groups in order to increase its affinity for the HA. The configuration of neuraminic acid places the carboxylate in the axial position is the alpha-anomer of neuraminic acid.

Present work was initiated with the modeling of the alpha-anomer of neuraminic acid and its derivatives having multiple substitutions at C-1, C-2, C-4, C-8 and C-9 positions. Molecular mechanics and molecular dynamics calculations were performed. The conformational behaviour of varying substituent holding side chains of neuraminic acid in aqueous environment were studied. The direct and water-mediated hydrogen bonds, which played a major role in the structural stability of neuraminic acid were also analyzed. Docking studies were done to study the binding mode of neuraminic acid derivatives into the binding pocket of Influenza HA.

MATERIALS AND METHODS {#sec1-1}
=====================

The modeled neuraminic acid derivatives with multiple substituents are shown in [Table 1](#T0001){ref-type="table"}. The neuraminic acid derivatives are designed as described by Sauter, *et al*., 1992\[[@CIT5]\] and Bianco, *et al*., 1998\[[@CIT6]\]. The initial conformations of the different substituent holding side chains of neuraminic acid analogues are defined as follows: for C-1 substitution, γ~1~=0 when C3-C2 cis to C1-O1A; γ~2~=0 when C2-C1 cis to O1A-C11, where C11 is the carbonyl carbon atom from the substitution group. For C-2 substitution, θ~1~=0 when C4-C3 cis to C2-O2; θ~2~=0 when C3-C2 cis to O2-C12, where C12 is the carbon attached to the substituent group. For C-4 substitution, β~1~=0 when C2-C3 cis to C4-O4; β~2~=0 when C3-C4 cis to O4-C13, where C13 is the carbon atom attached to the substituent group. For C-8 substitution, χ~1~=0 when C5-C6 cis to C7-C8; χ~3~=0 when C6-C7 cis to C8-O8. For C-9 substitution, χ~1~=0 when C5-C6 cis to C7-C8; χ~2~=0 when C6-C7 cis to C8-C9.

###### 

NEURAMINIC ACID ANALOGUES WITH MULTIPLE MODIFICATIONS

  Sialic acid derivative                                                                      Substituents                                                        
  ------------------------------------------------------------------------------------------- -------------- ------- ----------------------------------- -------- --------
                                                                                              R~1~           R~2~    R~3~                                R~4~     R~5~
                                                                                                                                                                  
  N-acetyl Neuraminic Acid                                                                    H              H       H                                   OH       OH
  methyl 5-N-acetyl neuraminate                                                               CH~3~          H       H                                   OH       OH
  methyl 2α-O-methyl-5-N-acetyl neuraminate                                                   CH~3~          CH~3~   H                                   OH       OH
  benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate                              CH~2~Ph        CH~3~   H                                   OCH~3~   OCH~3~
  benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate                CH~2~Ph        CH~3~   CO~2~(CH~2~)~6~CH~3~                OCH~3~   OCH~3~
  benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate                                     CH~2~Ph        CH~3~   CO~2~(CH~2~)~6~CH~3~                OH       OH
  2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid                                        H              CH~3~   CO~2~(CH~2~)~6~CH~3~                OH       OH
  benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-Oisopropylidene-neuraminate   CH~2~Ph        CH~3~   CO~2~(CH~2~)~7~O(CH~2~CH~2~)~2~NH   OCH~3~   OCH~3~
  benzyl-2α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetylneuraminate                       CH~2~Ph        CH~3~   CO~2~(CH~2~)~7~O(CH~2~CH~2~)~2~NH   OH       OH
  2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl neuraminic acid                          H              CH~3~   CO~2~(CH~2~)~7~O(CH~2~CH~2~)~2~NH   OH       OH
  5-N-acetyl-9-amino-9-deoxy neuraminic acid                                                  H              H       H                                   OH       NH~2~

Molecular mechanics calculations were carried out in the Pentium IV workstation using SANDER module of software AMBER10\[[@CIT7]\]. The force fields AMBER ff03 and gaff (general amber force field) were used. Water molecules are added from the solvent library of AMBER10 and care is given to maintain the number of water molecules to be same for all the neuraminic acid derivatives.

A periodic box enclosing the neuraminic acid analogues in solution is constructed to turn it into a periodic system for the simulation programs and periodic boundary conditions are applied on constant volume ([Table 2](#T0002){ref-type="table"}). The non bonded pair list was updated for every 10 steps. The non-bonded cutoff was specified as 8Å. For initial 100 cycles steepest descent method was used, then conjugate gradient is switched on. The convergence criterion for the energy gradient is less than 0.01kcal mole^-1^. The energy minimized structures for all the neuraminic acid derivatives are intensively analyzed through graphics software VEGA ZZ to work out the direct and solvent mediated hydrogen bonds.

###### 

THE BOX SIZE AND NUMBER OF ATOMS IN EACH NEURAMINIC ACID ANALOGUE WITH MULTIPLE MODIFICATIONS

  Sialic acid derivative                                                                      No of atoms   Box size(Å^3^)
  ------------------------------------------------------------------------------------------- ------------- ----------------------
  N-acetyl Neuraminic Acid                                                                    40            25.071×22.641×23.266
  methyl 5-N-acetyl neuraminate                                                               43            23.338×22.854×24.077
  methyl 2α-O-methyl-5-Nacetyl neuraminate                                                    46            24.734×23.343×22.600
  benzyl 2α-O-methyl-5-N-acetyl-8,9-Oisopropylidene neuraminate                               62            24.734×23.343×24.077
  benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate                85            21.402×30.414×21.022
  benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate                                     79            21.402×29.461×21.362
  2α-O-methyl-4-Ocapriloyl-5-N-acetyl neuraminic acid                                         66            23.338×21.568×26.582
  benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylideneneuraminate   98            20.772×32.158×21.362
  benzyl-2α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetyl-neuraminate                      92            20.086×30.511×23.266
  2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-Nacetyl neuraminic acid                           79            25.071×20.106×29.273
  5-N-acetyl-9-amino-9-deoxy neuraminic acid                                                  41            25.002×20.983×24.417

To understand the conformational dynamics of the neuraminic acid analogues in aqueous environment, molecular dynamics calculations were performed over a period of 30ps equilibration followed by a 2 ns production run with explicit inclusion of water molecules. The width of integration step of the MD simulation was 1fs. The history of information was recorded for every 1000 steps of trajectory which resulted in 2000 structures. The temperature was maintained to be 300K. The total simulation time was around 17 h for each molecule. The MD trajectory information collected for every 1ps were analyzed using PTRAJ (Trajectory Analysis) module of AMBER10 package.

Docking studies were done for all the 18 sialic acid analogues using Schrodinger (maestro). The protein is prepared by optimizing and minimizing the structure using Protein Preparation Wizard. The grid is generated using Receptor Grid Generation by picking the reference ligand which is already present in the PDB structure. HTVS is performed by importing 18 minimized sialic acid analogues using GLIDE module of Schrodinger software\[[@CIT8][@CIT9]\]. Induced fit is carried out for the five top scoring sialic acid analogues using Schrodinger to predict the ligand-induced conformational changes in receptor active sites\[[@CIT10]\].

RESULTS {#sec1-2}
=======

Relative energy of neuraminic acid derivatives: {#sec2-1}
-----------------------------------------------

The relative energy is calculated for all the 10 neuraminic acid derivatives with respect to the absolute minimum energy of neuraminic acid (-2395.1 kcal/mol). The minimum energy conformations of neuraminic acid derivatives with respect to their relative energy are displayed in [Table 3](#T0003){ref-type="table"}. Analogue 10 (5-N-acetyl-9-amino-9-deoxy neuraminic acid) is found to have the minimum energy equal to the minimum energy of neuraminic acid. Analogue 6 (2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid) has the relative minimum energy of 14.7 kcal/mol.

It is noted from [Table 3](#T0003){ref-type="table"} that, in the minimum energy conformation for Analogue 10 (5-N-acetyl-9-amino-9-deoxy neuraminic acid), the side chain conformations (χ~1,~ χ~2~) prefer values around (-177.11°,-90.33°). For Analogue 6 (2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid), the substituent dwelling side chain torsion angles (θ~1,~ θ~2~) and (β~1,~ β~2~) prefer the values (-69.48°,167.13°) and (-170.66°,-71.12°), respectively.

###### 

MINIMUM ENERGY CONFORMATIONS OF NEURAMINIC ACID ANALOGUES WITH MULTIPLE MODIFICATIONS IN AQUEOUS ENVIRONMENT

  Neuraminic acid derivative No   Relative energy kcal/mol   C1 substitution (γ~1~, γ~2~) (deg.)   C2 substitution (θ~1~,θ~2~) (deg.)   C4 substitution (β~1~, β~2~) (deg.)   C8 substitution (χ~1~, χ~3~) (deg.)   C9 substitution (χ~1~, χ~2~) (deg.)
  ------------------------------- -------------------------- ------------------------------------- ------------------------------------ ------------------------------------- ------------------------------------- -------------------------------------
  N-acetyl Neuraminic Acid        0                          \-                                    \-                                   \-                                    \-                                    \-
  1                               49.1                       (-52.53,-179.14)                      \-                                   \-                                    \-                                    \-
  2                               73.4                       (-70.20,171.27)                       (-74.43,171.39)                      \-                                    \-                                    \-
  3                               35.6                       (-100.06,179.65)                      (-68.74,-178.68)                     \-                                    (175.31,49.82)                        (175.31,-73.05)
  4                               76.7                       (-73.32,177.19)                       (-72.78,172.96)                      (-169.32,-69.33)                      (164.29,58.31)                        (164.29,-65.13)
  5                               28.1                       (-76.46,174.20)                       (-63.98,174.14)                      (-175.96,-73.03)                      \-                                    \-
  6                               14.7                       \-                                    (-69.48,167.13)                      (-170.66,-71.12)                      \-                                    \-
  7                               115.9                      (-68.53,178.43)                       (-62.98,172.91)                      (-177.16,-72.77)                      (-175.04,47.84)                       (-175.04,-75.38)
  8                               60.8                       (-93.66,-174.97)                      (-63.28,172.42)                      (-174.64,-72.59)                      \-                                    \-
  9                               75.4                       \-                                    (-72.59,175.08)                      (-168.97,-74.63)                      \-                                    \-
  10                              0                          \-                                    \-                                   \-                                    \-                                    (-177.11,-90.33)

Contribution of hydrogen bonds in structural stability: {#sec2-2}
-------------------------------------------------------

Figs. [1](#F0001){ref-type="fig"}--[3](#F0003){ref-type="fig"} showed the formation of water mediated hydrogen bonds and direct hydrogen bonds in neuraminic acid derivatives. It is well known from the previous findings that water mediated hydrogen bonds formed within the molecule plays a major role in stabilization of the molecule\[[@CIT11]\]. The water-mediated hydrogen bonds and direct hydrogen bonds are shown in [Table 4](#T0004){ref-type="table"}. Comparison of water mediated hydrogen bonds with direct hydrogen bonds revealed that analogue 10 (5-N-acetyl-9-amino-9-deoxy neuraminic acid) has 4 water mediated hydrogen bonds and 4 direct hydrogen bonds. The nitrogen atom from the substituted NH~2~ group contributed to both water mediated and direct hydrogen bond. It is also observed that analogue 6 (2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid) has three water mediated hydrogen bonds and three direct hydrogen bonds. It is inferred that the maximum number of direct and water mediated hydrogen bonds present in each neuraminic acid derivatives are responsible for the minimum energy and its stabilization of the molecule.

![The 3D structure of neuraminic acid analogues in global minimum energy conformation state.\
(a) N-acetyl neuraminic acid. (b) methyl 5-N-acetyl neuraminate (c) methyl 2 α-O-methyl-5-N-acetyl neuraminate (d) benzyl 2α-Omethyl- 5-N-acetyl-8,9-O-isopropylidene.](IJPhS-72-449-g002){#F0001}

![The 3D structure of neuraminic acid analogues in global minimum energy conformation state.\
(a) benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-Oisopropylidene neuraminate. (b) benzyl 2α-O-methyl-4-O-capriloyl- 5-N-acetyl-8,9-O-isopropylidene neuraminate (c) 2α-O-methyl-4-Ocapriloyl- 5-N-acetyl neuraminic acid (d) benzyl-2α-O-methyl-4-O-(8- morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate.](IJPhS-72-449-g003){#F0002}

![The 3D structure of neuraminic acid analogues in global minimum energy conformation state.\
(a) benzyl-2α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetylneuraminate. (b) 2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-Nacetyl neuraminic acid (c) N-acetyl-9-amino-9-deoxy neuraminic acid.](IJPhS-72-449-g004){#F0003}

###### 

HYDROGEN BONDS IN EACH NEURAMINIC ACID ANALOGUE WITH MULTIPLE MODIFICATIONS

  Sialic acid derivative                                                                       Interacting sialic acid derivative atom 1   Mediating water   Distance (Å)   Interacting sialic acid derivative atom2   Distance (Å)
  -------------------------------------------------------------------------------------------- ------------------------------------------- ----------------- -------------- ------------------------------------------ --------------
  N-acetyl neuraminic Acid                                                                     O10                                         WAT:180           2.77           O4                                         2.97
                                                                                               O2                                          WAT:9             2.91           O8                                         3.01
                                                                                               O1B                                         WAT:5             3.19           O9                                         3.01
                                                                                               O9                                          WAT:62            3.10           O7                                         3.08
                                                                                               O8                                                                           O7                                         3.01
                                                                                               O2                                                                           O1B                                        2.85
                                                                                               O4                                                                           N5                                         2.93
  methyl 5-N-acetyl neuraminate                                                                O10                                         WAT:131           2.88           O7                                         2.74
                                                                                               O2                                          WAT: 165          3.17           O7                                         3.10
                                                                                               O4                                                                           N5                                         2.81
                                                                                               O2                                                                           O1B                                        2.79
  methyl 2α-0-methyl-5-N-acetyl neuraminate                                                    O7                                          WAT: 176          2.60           O10                                        3.07
                                                                                               O1A                                         WAT: 74           2.85           O10                                        3.03
                                                                                               O2                                                                           O1B                                        2.82
                                                                                               O8                                                                           O9                                         3.02
                                                                                               O8                                                                           O7                                         2.96
                                                                                               O4                                                                           N5                                         2.99
  benzyl 2α-0-methyl-5-N-acetyl-8,9-0-isopropylidene neuraminate                               O7                                          WAT: 19           2.67           O9                                         3.13
                                                                                               O7                                          WAT: 2            3.14           O2                                         2.81
                                                                                               O2                                                                           O1B                                        2.94
                                                                                               O4                                                                           N5                                         3.01
                                                                                               O8                                                                           O9                                         3.21
  benzyl 2α-0-methyl-4-0-capriloyl-5-II-acetyl-8,9-0-isopropylidene neuraminate                O10                                         WAT: 181          2.90           O11[\*](#T000F1){ref-type="table-fn"}      3.17
                                                                                               O9                                          WAT: 121          2.86           O2                                         2.88
                                                                                               N5                                                                           O4                                         2.92
                                                                                               O8                                                                           O7                                         2.81
  benzyl 2α-0-methyl-4-0-capryloil-5-ll-acetyl neuraminate                                     O2                                          WAT: 193          3.03           O9                                         2.71
                                                                                               O10                                         WAT: 126          2.48           O11                                        3.19
                                                                                               O7                                                                           O8                                         2.91
                                                                                               O8                                                                           O9                                         2.90
                                                                                               O2                                                                           O1B                                        2.80
                                                                                               N5                                                                           O4                                         2.87
  2α-0-methyl-4-0-capriloyl-5-N-acetyl neuraminic acid                                         O7                                          WAT: 75           2.59           O10                                        2.81
                                                                                               O10                                         WAT: 169          2.87           O11[\*](#T000F1){ref-type="table-fn"}      2.80
                                                                                               O1A                                         WAT: 71           3.20           O9                                         3.07
                                                                                               N5                                                                           O4                                         2.82
                                                                                               O2                                                                           O1B                                        3.06
                                                                                               O7                                                                           O8                                         2.95
  benzyl-2α-0-methyl-4-0-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate   O8                                          WAT: 166          2.65           O2                                         3.08
                                                                                               N18[\*](#T000F1){ref-type="table-fn"}                                        O20[\*](#T000F1){ref-type="table-fn"}      2.87
                                                                                               N5                                                                           O4                                         2.86
                                                                                               O2                                                                           O1B                                        2.84
                                                                                               O7                                                                           O8                                         2.98
  benzyl-2α-0-methyl-4-0-(8-morpholin)-capriytoyl-5-N-acetyl-neuraminate                       O1B                                         WAT: 199          3.07           O4                                         2.93
                                                                                               O11[\*](#T000F1){ref-type="table-fn"}       WAT: 198          3.03           O10                                        2.42
                                                                                               O8                                                                           O7                                         2.88
                                                                                               O9                                                                           O8                                         3.13
                                                                                               O2                                                                           O1B                                        2.90
                                                                                               N5                                                                           O4                                         2.78
                                                                                               N18[\*](#T000F1){ref-type="table-fn"}                                        O20[\*](#T000F1){ref-type="table-fn"}      2.88
  2α-0-methyl-4-0-(8-morpholin)-capriloyl-5-ll-acetyl neuraminic acid                          O9                                          WAT: 82           3.04           O7                                         2.48
                                                                                               O9                                          WAT:81            2.89           O1A                                        2.83
                                                                                               N18[\*](#T000F1){ref-type="table-fn"}                                        O20[\*](#T000F1){ref-type="table-fn"}      2.88
                                                                                               O8                                                                           O7                                         2.96
                                                                                               O2                                                                           O1B                                        2.87
                                                                                               O4                                                                           N5                                         2.85
  5-H-acetyl-9-amino-9-deoxy neuraminic acid                                                   O1B                                         WAT:44            2.75           N9[\*](#T000F1){ref-type="table-fn"}       3.10
                                                                                               O10                                         WAT: 177          3.14           O7                                         2.90
                                                                                               O4                                          WAT: 193          3.04           O2                                         2.68
                                                                                               O5                                          WAT: 146          2.71           O10                                        2.89
                                                                                               O8                                                                           N9[\*](#T000F1){ref-type="table-fn"}       2.52
                                                                                               O7                                                                           O8                                         3.21
                                                                                               N5                                                                           O4                                         3.05
                                                                                               O2                                                                           O1B                                        2.81

is the atom from the substituent group.

Molecular dynamics of sialic acid analogues: {#sec2-3}
--------------------------------------------

To study the conformational dynamics of the neuraminic acid derivatives, a 2ns molecular dynamics simulation was carried out. An in-depth analysis on the conformational features of all the 10 neuraminic acid analogues was done by collecting the frames for every 1ps.

C-1 substituted side chain conformation: {#sec2-4}
----------------------------------------

For analogue 1 (methyl 5-N-acetyl neuraminate), the dihedral angles γ~1~ and γ~2~ exhibit a bifurcation throughout the molecular dynamics simulation. The torsional angle γ~1~ of analogue 2 (methyl 2α-O-methyl-5-N-acetyl neuraminate), analogue 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), analogue 4 (benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), analogue 5 (benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate) and analogue 8 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetyl-neuraminate) shows good distribution throughout the MD simulation, however γ~2~ is rigid in +180° and -180° regions. The shift of γ~1~ from -180° region to +70° region results in the energy decrease of 5 kcal/mol. [Fig. 4a](#F0004){ref-type="fig"} shows the molecular dynamic trajectory showing transitions of the substituent holding side chain torsion angles γ~1~ and γ~2~ along with (γ~1,~ γ~2~) distribution plot of analogue 5 (benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate). In the case of analogue 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate), γ~1~ bifurcates in negative regions such as -180°, -120° and -60°, whereas γ~2~ prefers +180° and -180° region.

![Molecular dynamics trajectory and the distribution plots of sialic acid analogues\
(a) γ~1~ V~s~ γ~2~ plots for benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate, (b) θ~1~ Vs θ~2~ distribution plots for 2α-O-methyl-4-Ocapriloyl-5-N-acetyl neuraminic acid (c) β~1~V~s~ β~2~ plots for 2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid.](IJPhS-72-449-g005){#F0004}

C-2 substituted side chain conformation: {#sec2-5}
----------------------------------------

For analogue 2 (methyl 2α-O-methyl-5-N-acetyl neuraminate), 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), 4 (benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), 5 (benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate), 6 (2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid) and 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate), θ~1~ is rigid in -60° region and θ~2~ prefers +180° and -180° regions. [Fig. 4b](#F0004){ref-type="fig"} represents the dynamic behavior of torsions θ~1~ and θ~2~ along with (θ~1,~θ~2~) distribution plot of 2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid (analogue 6) in aqueous environment.

However the dihedral angle θ~2~ of analogue 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), analogue 5 (benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate) and analogue 6 (2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid) exhibits an additional bifurcation in -60° region. In the case of analogue 8 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetyl-neuraminate), θ~1~ prefers -70° region and θ~2~ prefers +180°, -180° and -70° regions.

C-4 substituted side chain conformation: {#sec2-6}
----------------------------------------

β~1~ of analogue 4 (benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), 5 (benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate), 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate), and 8 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetyl-neuraminate) prefers +180° and -180° regions. β~2~ of analogue 5 (benzyl 2α-O-methyl-4-O-capryloil-5-N-acetyl neuraminate), 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate) and 8 (benzyl-2 α-O-methyl-4-O-(8-morpholin)-capriyloyl-5-N-acetyl-neuraminate) prefers -180° and -70° regions. β~2~ of analogue 4 (benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate) prefers -180°, -120°, +180° and -60° regions.

For analogue 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate), the shift of β 2 from -70° to -180° region results in the energy decrease of up to 6 kcal/mol. In the case of analogue 6 (2α-O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid), β~2~ shows good distribution in -180°, +180°, -70° and +60° regions. β~1~ prefers +180° and -180° regions. [Fig. 4c](#F0004){ref-type="fig"} represents the dynamic behavior of torsions β~1~ and β~2~ along with (β~1,~β~2~) distribution plot of 2α -O-methyl-4-O-capriloyl-5-N-acetyl neuraminic acid (analogue 6) in aqueous environment.

C-8 substituted side chain conformation: {#sec2-7}
----------------------------------------

For analogue 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), analogue 4 (benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate) and analogue 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene-neuraminate), χ~1~ prefers +180° and -180° regions and χ~3~ is rigid in +70° region. [Fig. 5a](#F0005){ref-type="fig"} describes the molecular dynamic trajectory showing transitions of the different substituent holding side chain torsion angles χ~1~ and χ~3~ along with (χ~1,~χ~3~) distribution plot of analogue 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate).

![Molecular dynamics trajectory and the distribution plots (a) χ~1~ V~s~ χ~3~ plots for benzyl 2α-O-methyl-5-N-acetyl-8,9-Oisopropylidene neuraminate, (b) χ~1~ V~s~ χ~2~ plots for benzyl 2α-Omethyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate and (c) χ~1~ Vs χ~2~ plots for 5-N-Acetyl-9-amino-9-deoxy neuraminic acid](IJPhS-72-449-g006){#F0005}

C-9 substituted side chain conformation: {#sec2-8}
----------------------------------------

χ~1~ analogue 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate), 4 (benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate) and 7 (benzyl-2α-O-methyl-4-O-(8-morpholin)-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate) prefers +180° and -180° regions and χ~2~ prefers -70° region. In the case of analogue 10 (5-N-acetyl-9-amino-9-deoxy neuraminic acid), χ~1~ prefers -180° +60° and +180° regions and χ~2~ shows bifurcation in -70°, +70°, +180° and -180° regions. The shift of χ~1~ from -180° region to +60° region resulted in the energy decrease of up to 10kcal/mol. [Fig. 5](#F0005){ref-type="fig"} (b and c) represents the dynamic behavior of torsions χ~1~ and χ~2~ along with (χ~1~, χ~2~) distribution plot of neuraminic acid analogues benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate (analogue 4) and 5-N-acetyl-9-amino-9-deoxy neuraminic acid (analogue 10) in aqueous environment.

Modeling of sialic acid analogues and Influenza hemagglutinin complexes: {#sec2-9}
------------------------------------------------------------------------

High Throughput Virtual Screening was done for ten neuraminic acid analogues to find out the structures (ligands) most likely to bind to the Influenza hemagglutinin. The top five ligands with best docking score and minimum energy are subjected to induced fit docking. The glide score along with the glide energy is displayed in [Table 5](#T0005){ref-type="table"}. The inter-molecular interactions between the top five ligands and the Influenza hemagglutinin are noted and displayed in [Table 6](#T0006){ref-type="table"}. Figs. [6](#F0006){ref-type="fig"} and [7](#F0007){ref-type="fig"} shows the neuraminic acid analogues 3 (benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate) and 10 (5-N-acetyl-9-amino-9-deoxy neuraminic acid) at the active site of Influenza HA, respectively. The bound state conformations of the substituent holding side chains of sialic acid analogues are displayed in [Table 7](#T0007){ref-type="table"}.

![Sialic acid analogue (2α-O-methyl-5-N-acetyl-8,9-Oisopropylidene neuraminate) at the active site of Influenza Hemagglutinin](IJPhS-72-449-g007){#F0006}

![Sialic acid analogue (5-N-acetyl-9-amino-9-deoxy neuraminic acid) at the active site of Infl uenza Hemagglutinin](IJPhS-72-449-g008){#F0007}

###### 

GLIDE DOCKING SCORE AND GLIDE ENERGY OF INFLUENZA HEMAGGLUTININ - NEURAMINIC ACID COMPLEXES

  Analogue no   Neuraminic acid derivative                                                     Glide energy (kcal/mol)   Glide score
  ------------- ------------------------------------------------------------------------------ ------------------------- -------------
  5             Benzyl 2a-O-methyl-4-O-capryloil-5-N-acetyl Neuraminate                        -54.64                    -8.64
  10            5-N-Acetyl-9-amino-9-deoxy Neuraminic Acid                                     -36.70                    -7.73
  2             5-N-Acetyl-9-amino-9-deoxy Neuraminic Acid                                     -42.87                    -7.71
  4             Benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene Neuraminate   -45.91                    -6.71
  3             Benzyl 2a-O-methyl-5-N-acetyl-8,9-O-isopropylidene Neuraminate                 -42.16                    -5.34

###### 

INTER-MOLECULAR INTERACTIONS BETWEEN THE NEURAMINIC ACID ANALOGUES AND INFLUENZA HEMAGGLUTININ

  Analogue no   Neuraminic acid derivative                                                     Ligand atom   Protein   Distance (Å)   
  ------------- ------------------------------------------------------------------------------ ------------- --------- -------------- -------
  5             Benzyl 2a-O-methyl-4-O-capryloil-5-N-acetyl Neuraminate                        O8            GLU:225   OE1            2.677
                                                                                               O9            GLU:225   OE1            2.698
                                                                                               O9            GLY:227   N              2.338
  10            5-N-Acetyl-9-amino-9-deoxy Neuraminic Acid                                     N             GLY:134   O              3.061
                                                                                               O1            GLY:134   O              2.748
                                                                                               N9            ASN:185   OD1            3.261
                                                                                               N             GLU:189   OE1            2.913
                                                                                               O10           GLN:225   OE1            2.901
  2             Methyl 2α-O-methyl-5-N-acetyl Neuraminate                                      O9            GLY:134   O              2.798
                                                                                               O2            GLU:189   OE1            2.677
                                                                                               O1            TYR:95    OH             2.675
  3             Benzyl 2a-O-methyl-5-N-acetyl-8,9-O-isopropylidene Neuraminate                 O7            GLU:189   OE1            2.830
  4             Benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene Neuraminate   O9            GLU:225   OE1            2.743
                                                                                               O7            GLY:134   OE1            2.991
                                                                                               O4            GLU:225   O              2.936

###### 

BOUND STATE CONFORMATIONS OF THE SUBSTITUENT HOLDING SIDE CHAINS OF SIALIC ACID ANALOGUES

  Neuraminic acid Analogue No   C1 substitution (γ~1~, γ~2~) (deg.)   C2 substitution (θ~1~,θ~2~) (deg.)   C4 substitution (β ~1~, β ~2~) (deg.)   C8 substitution (χ ~1~, χ ~3~) (deg.)   C9 substitution (χ ~1~, χ ~2~) (deg.)
  ----------------------------- ------------------------------------- ------------------------------------ --------------------------------------- --------------------------------------- ---------------------------------------
                                \-                                    \-                                   \-                                      \-                                      \-
  2                             (47.8,-179.9)                         (-66.4,-178.7)                       \-                                      \-                                      \-
  3                             (92.0,171.9)                          (-74.7,166.5)                        \-                                      (102.9,-63.0)                           (102.9,-176.5)
  4                             (48.1,179.7)                          (-63.7,-54.1)                        (-178.0,-74.1)                          (-171.4,50.3)                           (-171.4,-75.0)
  5                             (13.8,158.0)                          (-66.1,-138.7)                       (-172.8,-63.6)                          \-                                      \-
  10                            \-                                    \-                                   \-                                      \-                                      (-173.5,96.1)

DISCUSSION {#sec1-3}
==========

The current study reveals the probable conformational models for neuraminic acid derivatives with multiple substitutions at positions C-1/C-2/C-4/C-8/C-9 in aqueous environment. Water mediated hydrogen bonding interaction plays a dominant role in stabilizing the conformational structures of these neuraminic acid derivatives. The accessible conformations for neuraminic acid analogues with multiple substituents holding side chain linkages observed by the present MD study correlate well with those reported for similar linkages in various Neu5Ac-α2→8-Neu5Ac moiety present in all the di- and tri-sialogangliosides by earlier studies\[[@CIT11][@CIT12]\]. Present MD results show a dynamic behaviour for χ~1~ of analogue 10 (5-N-acetyl-9-amino-9-deoxy neuraminic acid) at the cost of 10 kcal/mol ([Fig. 5c](#F0005){ref-type="fig"}), which is a vivid indication that this molecule prefers -60° region. Analogue 10 is observed to have the lowest energy of -2395.1 kcal/mol when compared to other neuraminic acid analogues with multiple substituents and it shows good results in hydrogen bonding interactions with four water mediated hydrogen bonds and four direct hydrogen bonds. The nitrogen from the substituted NH~2~ group contributes to both water mediated and direct hydrogen bond. Docking studies show the mode of binding of sialic acid derivatives into the binding pocket of Influenza hemagglutinin which in turn explains their order of specificity. It is very interesting to know that the neuraminic acid analogues, benzyl 2α -O-methyl-4-O-capryloil-5-N-acetyl neuraminate (analogue 5), 5-N-acetyl-9-amino-9-deoxy neuraminic acid (analogue 10), 5-N-acetyl-9-amino-9-deoxy neuraminic acid (analogue 2), benzyl 2α-O-methyl-4-O-capriloyl-5-N-acetyl-8,9-O-isopropylidene neuraminate (analogue 4) and benzyl 2α-O-methyl-5-N-acetyl-8,9-O-isopropylidene neuraminate (analogue 3) have greater docking score than the co-crystal ligand (PDB reference ligand) such as -8.64, -7.73, -7.71, -6.71 and -5.34, respectively and minimum energy such as -54.64 kcal/mol, -36.70 kcal/mol, -42.87 kcal/mol, -45.91 kcal/mol and -42.16 kcal/mol, respectively.

The present study provides accessible conformational models for synthetic neuraminic acid analogues with multiple substituents at positions C-1, C-2, C-4, C-8 or C-1 in aqueous environment. Direct and water mediated hydrogen bonding schemes greatly involve in stabilizing the three dimensional conformational structures of these neuraminic acid analogues. This study also shows the dynamics trajectory and distribution plot for the substituent holding side chain linkages of the neuraminic acid analogues. The high affinity inhibitors modeled in this study saturate the hemagglutinin (HA) receptor\[[@CIT5]\] and can be used as potential antiinfluenza drugs.
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